Rivastigmine for Delirium After Stroke
Author Information
Author(s): Annemarie W Oldenbeuving, Paul LM de Kort, Ben PW Jansen, L Jaap Kappelle, Gerwin Roks
Primary Institution: St Elisabeth Hospital, Tilburg, the Netherlands
Hypothesis
Can rivastigmine be safely used to treat delirium in stroke patients?
Conclusion
Rivastigmine is safe in stroke patients with delirium and can improve symptoms.
Supporting Evidence
- 16 out of 17 patients showed a decrease in delirium severity after treatment.
- The mean Delirium Rating Scale score decreased from 14.8 to 5.6 after tapering off rivastigmine.
- Rivastigmine was well tolerated with no major side effects reported.
Takeaway
This study tested a medicine called rivastigmine to help people who get confused after a stroke, and it seemed to work well without causing big problems.
Methodology
The study involved 527 stroke patients, assessing delirium presence and severity, with 26 patients treated with rivastigmine.
Potential Biases
The study design and small sample size may introduce bias.
Limitations
The study was small and uncontrolled, limiting conclusions about the treatment's effectiveness.
Participant Demographics
Mean age of treated patients was 77 years, with 65% being men.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website